CROI 2020 Program and Conference Information

General Information

IAS–USA The International Antiviral (formerly AIDS) Society–USA (IAS–USA) serves as the Conference Organizer for the logistical planning and organization for CROI in partnership with the CROI Foundation and Program Committee.The mission of the IAS–USA is to improve the prevention, treatment, care, and quality of life for people with or at risk of HIV or other viral infections and their associated health conditions through high-quality, relevant, balanced, and needs-oriented education and information for practitioners and scientists who are actively involved in medical care and research. To access primary educational and informational programs sponsored by the IAS–USA, please visit www.iasusa.org for:

General Information

• Live CME courses and webinars available for signup • Archived webcasts of CME courses and webinars • Topics in Antiviral Medicine ™, including the annual CROI review • Practice guidelines

CONTINUING MEDICAL EDUCATION Accreditation Statement The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The IAS–USA designates this live activity for a maximum of 17.50 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Objectives After participating in CROI 2020, participants will be able to: • Describe basic science research advances in HIV • List the most recent findings from clinical trials in the field of HIV and the implications of these data for state-of-the-art treatment strategies • Describe current epidemiologic data on the prevalence of HIV infection, transmission, treatment, and linkage to and retention in care in populations worldwide; the implications of these data for public-health program planning; and current advances in biobehavioral prevention Statement of Need Since HIV was identified, the scientific response to the global pandemic has been a coordinated effort among basic researchers, clinical investigators, health care providers, epidemiologists, and community leaders to move information and potential treatment options from research to clinical trials and out to affected communities as quickly as possible. CROI was founded in 1993, by researchers working in the field of HIV/AIDS and its complications, as a science-focused forum for exchanging current research findings among their international peers. CROI continues to focus on scientific exchange, providing an environment in which basic science researchers, translational researchers, clinical investigators, epidemiologists, and public health experts meet to present and discuss the latest research into different facets of HIV and its complications, as well as selected other emerging infections.

CROI 2020 3